PATENT CLAIM ANALYSIS

Application Number: 15923050
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "017700"]

Abstract:
Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.

Claim (Index 66):
The method of  claim 53 , wherein (a) said blood levels are induced by an intravenous anti-emetic regimen administered prior to said chemotherapy, and (2) said blood levels are equivalent to blood levels induced by 300 mg of netupitant free base and 0.56 mg palonosetron hydrochloride administered orally.

Metadata:
- Claim Count in Document: 212.0
- Percentile: 90.0
- Lexical Diversity: 1.15789
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14069927', '13077462', '15003327', '14069970', '14069885']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8607806695721528
- 35 USC 102 Novelty (BERT): 0.6627221715374113
- Combined Prediction Score: 0.8409748197686786
- Mean Citation Score: 677.586414
- Max Citation Score: 749.77997
- Similarity Product: 596.8721413903438

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test